Although not included in the IPSS-R for calculation of the number of cytogenetic abnormalities, CN-LOH, specifically involving TP53 gene is necessary for allele state determination and MDS prognostication using the latest IPSS-M [49]. The gene discussed is TP53; the disease is myelodysplastic syndrome.